Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathological and clinical effects of interleukin-6 on human myocarditis.
Amioka N, Nakamura K, Kimura T, Ohta-Ogo K, Tanaka T, Toji T, Akagi S, Nakagawa K, Toh N, Yoshida M, Miyoshi T, Nishii N, Watanabe A, Asano R, Ogo T, Nakaoka Y, Morita H, Yanai H, Ito H. Amioka N, et al. Among authors: nakaoka y. J Cardiol. 2021 Aug;78(2):157-165. doi: 10.1016/j.jjcc.2021.03.003. Epub 2021 Apr 2. J Cardiol. 2021. PMID: 33814251 Free article.
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension.
Masaki T, Okazawa M, Asano R, Inagaki T, Ishibashi T, Yamagishi A, Umeki-Mizushima S, Nishimura M, Manabe Y, Ishibashi-Ueda H, Shirai M, Tsuchimochi H, Pearson JT, Kumanogoh A, Sakata Y, Ogo T, Kishimoto T, Nakaoka Y. Masaki T, et al. Among authors: nakaoka y. Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2023899118. doi: 10.1073/pnas.2023899118. Proc Natl Acad Sci U S A. 2021. PMID: 33836606 Free PMC article.
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
Yaku A, Inagaki T, Asano R, Okazawa M, Mori H, Sato A, Hia F, Masaki T, Manabe Y, Ishibashi T, Vandenbon A, Nakatsuka Y, Akaki K, Yoshinaga M, Uehata T, Mino T, Morita S, Ishibashi-Ueda H, Morinobu A, Tsujimura T, Ogo T, Nakaoka Y, Takeuchi O. Yaku A, et al. Among authors: nakaoka y. Circulation. 2022 Sep 27;146(13):1006-1022. doi: 10.1161/CIRCULATIONAHA.122.059435. Epub 2022 Aug 23. Circulation. 2022. PMID: 35997026
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis.
Manabe Y, Ishibashi T, Asano R, Tonomura S, Maeda Y, Motooka D, Ueda J, Yanagawa M, Edamoto-Taira Y, Chikaishi-Kirino T, Masaki T, Inagaki T, Nakamura S, Katada Y, Okazawa M, Narazaki M, Ogo T, Kumanogoh A, Nakaoka Y. Manabe Y, et al. Among authors: nakaoka y. Arthritis Res Ther. 2023 Mar 24;25(1):46. doi: 10.1186/s13075-023-03031-9. Arthritis Res Ther. 2023. PMID: 36964623 Free PMC article.
IL-6/gp130 signaling in CD4+ T cells drives the pathogenesis of pulmonary hypertension.
Ishibashi T, Inagaki T, Okazawa M, Yamagishi A, Ohta-Ogo K, Asano R, Masaki T, Kotani Y, Ding X, Chikaishi-Kirino T, Maedera N, Shirai M, Hatakeyama K, Kubota Y, Kishimoto T, Nakaoka Y. Ishibashi T, et al. Among authors: nakaoka y. Proc Natl Acad Sci U S A. 2024 Apr 16;121(16):e2315123121. doi: 10.1073/pnas.2315123121. Epub 2024 Apr 11. Proc Natl Acad Sci U S A. 2024. PMID: 38602915 Free PMC article.
Biomarkers for Takayasu arteritis: Which is the most promising?
Ishibashi T, Nakaoka Y. Ishibashi T, et al. Among authors: nakaoka y. Int J Cardiol. 2023 Jan 15;371:418-419. doi: 10.1016/j.ijcard.2022.09.048. Epub 2022 Sep 27. Int J Cardiol. 2023. PMID: 36174823 No abstract available.
236 results